Board Meeting2 Nov 2026, 08:50 pm
Sampre Nutritions Board Meeting on Nov 6 to Approve Q2 Results
AI Summary
Sampre Nutritions Limited has announced that its Board of Directors will convene on November 6, 2026. The primary agenda item for this meeting is the consideration and approval of the unaudited standalone and consolidated financial results for the second quarter, which ended on September 30, 2026, for the financial year 2026-27. This meeting is being held in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Board meeting scheduled for November 6, 2026.
- To consider and approve Q2 FY27 unaudited financial results.
- Both standalone and consolidated results will be reviewed.
- Compliance with SEBI Listing Regulations is noted.
Price Impact
More from SAMPRE